HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Johannes Rheinlaender Selected Research
Johannes Rheinlaender Research Topics
Disease
4
Thrombosis (Thrombus)
10/2018 - 12/2015
3
Coronary Artery Disease (Coronary Atherosclerosis)
05/2022 - 07/2017
2
Inflammation (Inflammations)
10/2018 - 12/2015
1
Genetic Predisposition to Disease (Genetic Predisposition)
05/2022
1
Thrombocytopenia (Thrombopenia)
01/2022
1
Thromboinflammation
01/2022
1
Neoplasms (Cancer)
04/2021
1
Cardiovascular Diseases (Cardiovascular Disease)
10/2018
1
Myocardial Infarction
10/2018
1
Acute Coronary Syndrome
07/2017
1
Carotid Artery Injuries
07/2017
1
Wounds and Injuries (Trauma)
12/2015
1
Hemorrhagic Shock
12/2015
1
Endocarditis
05/2014
1
Keratoconus
01/2014
1
Neuroacanthocytosis
01/2013
1
Necrosis
01/2013
Drug/Important Bio-Agent (IBA)
2
Lipids
IBA
01/2022 - 07/2017
2
Proteins (Proteins, Gene)
FDA Link
05/2014 - 01/2013
1
Junctional Adhesion Molecule A
IBA
05/2022
1
Heparin (Liquaemin)
FDA Link
Generic
01/2022
1
Immunoglobulin G (IgG)
IBA
01/2022
1
Glycoproteins (Glycoprotein)
IBA
10/2018
1
Anaphylatoxins
IBA
10/2018
1
Complement System Proteins (Complement)
IBA
10/2018
1
CXCR Receptors
IBA
07/2017
1
Chemokine CXCL12
IBA
07/2017
1
oxidized low density lipoprotein
IBA
07/2017
1
ferric chloride
IBA
07/2017
1
Thrombin
FDA Link
01/2017
1
HMGB1 Protein (HMG1)
IBA
12/2015
1
Quartz
IBA
05/2014
1
Riboflavin (Vitamin B2)
FDA Link
Generic
01/2014
1
Caspase 3 (Caspase-3)
IBA
01/2013
Therapy/Procedure
1
Traction
04/2021
1
Corneal Cross-Linking
01/2014